Squamous Cell Carcinomas (SSC) is an epithelial malignancy that can arise from different tissue types including lung, cervix, esophagus, anal canal, skin, and head and neck.2 Squamous Cell Carcinoma Antigen (SCCA) concentrations are elevated in the blood of patients with cervical, lung, and head and neck cancers. More than 90% of head and neck cancers, 30% of Non-Small Cell Lung cancers2 and 80% of cervical cancers are SCCs.3 Advanced stages of these cancers are associated with higher SCCA concentrations especially in lung and cervix.
SCC of the Lungs
SCC of the Cervix
SCCA is considered the most useful marker for cervical SCC. The European Group of Tumor Markers (EGTM) recognizes SCCA as the tumor marker of choice for the follow-up of cervical cancer. Most cases are caused by infection with human papillomavirus (HPV), which is preventable with a vaccine.
SCC of the Head and Neck (SCCHN)
Atellica® IM and ADVIA Centaur® SCC Assay*
The Siemens Healthineers SCC assay can accurately detect SCCA concentrations, which in conjunction with other clinical and laboratory findings, aids clinicians in treating their patients with squamous cell carcinomas.
- Rapid and precise measurement of SCC antigen concentrations to monitor disease progression and treatment.
- Utilizes trusted Acridinium Ester, technology, coupled with two highly specific monoclonal antibodies.
- Confidence in results with an assay that detects equimolar SCCA1 and SCCA2 enabling measurement of total SCCA.16